Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
D000328:Adult; D000368:Aged; D000880:Anthraquinones / Q000627:therapeutic use / Q000633:toxicity*; D000970:Antineoplastic Agents / Q000633:toxicity*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D008942:Mitoxantrone; D009362:Neoplasm Metastasis; D011960:Receptors, Estrogen / Q000032:analysis
D000880:Anthraquinones; D000970:Antineoplastic Agents; D011960:Receptors, Estrogen; D008942:Mitoxantrone